Branched chain amino acids as adjunctive therapy to ketogenic diet in epilepsy: Pilot study and hypothesis

Journal of Child Neurology

Volumn 24, Issue 10, 2009, Pages 1268-1272

  Evangeliou, Athanasios ^a   Spilioti, Martha ^b   Doulioglou, Vai ^a   Kalaidopoulou, Panagiota ^a   Ilias, Anestis ^a   Skarpalezou, Astrinia ^c   Katsanika, Irini ^a   Kalamitsou, Serafia ^a   Vasilaki, Konstantina ^a   Chatziioanidis, Ilias ^a   Garganis, Kiriakos ^d   Pavlou, Evangelos ^a   Varlamis, Sotirios ^a   Nikolaidis, Nikolaos ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b UNIVERSITY OF CRETE   (Greece)

^c AGHIA SOPHIA CHILDREN S HOSPITAL   (Greece)

^d Agios Loukas Hospital   (Greece)

Author keywords

Branched chain amino acids; Intractable epilepsy; Ketogenic diet

Indexed keywords

ANTICONVULSIVE AGENT; BRANCHED CHAIN AMINO ACID; ISOLEUCINE; KETONE; LEUCINE; VALINE;

ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE CONTROL; EPILEPSY; FOLLOW UP; HEART RATE; HUMAN; HYPOTHESIS; KETOGENIC DIET; NUTRITIONAL TOLERANCE; PILOT STUDY; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SIDE EFFECT; TREATMENT DURATION; TREATMENT RESPONSE; URINALYSIS; BIOLOGICAL MODEL; CLINICAL TRIAL; DIET THERAPY; KETOACIDOSIS; PROSPECTIVE STUDY; SEIZURE; TREATMENT OUTCOME; URINE;

AMINO ACIDS, BRANCHED-CHAIN; ANTICONVULSANTS; CHILD; CHILD, PRESCHOOL; EPILEPSY; FOLLOW-UP STUDIES; HUMANS; KETOGENIC DIET; KETOSIS; MODELS, BIOLOGICAL; PILOT PROJECTS; PROSPECTIVE STUDIES; SEIZURES; TREATMENT OUTCOME;

EID: 74949099550     PISSN: 08830738     EISSN: 17088283     Source Type: Journal    
DOI: 10.1177/0883073809336295     Document Type: Article

References (24)

1. Kang HC, Chung DE, Kim DW, Kim HD. Early-and late-onset complications of the ketogenic diet for intractable epilepsy. Epilepsia. 2004;45(9):1116-1123.
2. Freeman JM, Kossoff EH, Hartman AL. The ketogenic diet: one decade later. Pediatrics. 2007;119(3):535-543.
3. Kossoff EH, Krauss GL, Mc Grogan JR, Freeman JM. Efficacy of the Atkins diet as therapy for intractable epilepsy. Neurology. 2003;61(12):1789- 1791.
4. Pfeifer HH, Thiele EA. Low-glycemic-index treatment: a liberalized ketogenic diet for treatment of intractable epilepsy. Neurology. 2005;65(11):1810-1812.
5. Yudkoff M, Daikhin Y, Nissim I, et al. Brain amino acid requirements and toxicity: the example of leucine. J Nutr. 2005;135(6 suppl):1531S-1538S.
6. Shimomura Y, Harris RA. Metabolism and physiological function of branched-chain amino acids: discussion of session 1. J Nutr. 2006;136(1 suppl):232S-233S.
7. Ribeiro CA, Sgaravatti AM, Rosa RB, et al. Inhibition of brain energy metabolism by the branched-chain amino acids accumulating in maple syrup urine disease. Neurochem Res. 2007;33(1):114-124.
8. Lee S, Turner M, Lee G. Brain Chip for Biochemistry. 1st ed. Oxford, UK: Blackwell Publishing; 2002.
9. Brosnan JT, Brosnan ME. Branched-chain amino acids: enzyme and substrate regulation. J Nutr. 2006;136(1 suppl):207S-211S.
10. Yudkoff M, Daikhin Y, Nissim I, Lazarow A, Nissim I. Ketogenic diet, brain glutamate metabolism and seizure control. Prostaglandins Leukot Essent Fatty Acids. 2004;70(3):277-285.
11. Dahlin M, Elfving A, Ungerstedt U, Amark P. The ketogenic diet influences the levels of excitatory and inhibitory amino acids in the CSF in children with refractory epilepsy. Epilepsy Res. 2005;64(3):115-125.
12. Hutson SM, Lieth E, La Noue KF. Function of leucine in excitatory neurotransmitter metabolism in the central nervous system. J Nutr. 2001;131(3):846S-850S.
13. Hutson SM, Berkich DA, Drown P, Xu B, Aschner M, LaNoue KF. Role of branched chain aminotransferase isoenzymes and gabapentin in neurotransmitter metabolism. J Neuro Chem. 1998;71(2):863-874.
14. Plaitakis A, Smith J, Mandeli J, Yahr MD. Pilot trial of branched-chain aminoacids in amyotrophic lateral sclerosis. Lancet. 1988;1(8593):1015- 1018.
15. Plaitakis A. Abnormal glutamatergic mechanisms and branchedchain aminoacids in amyotrophic lateral sclerosis. Lancet. 1989;1(8630):157.
16. Malthankar-Phatak GH, de Lanerolle N, Eid T, et al. Differential glutamate dehydrogenase (GDH) activity profile in patients with temporal lobe epilepsy. Epilepsia. 2006;47(8):1292-1299.
17. Dufour F, Nalecz KA, Nalecz MJ, Nehlig A. Modulation of absence seizures by branched-chain amino acids: correlation with brain amino acid concentrations. Neurosci Res. 2001;40(3):255-263.
18. Yudkoff M, Daikhin Y, Nissim I, et al. Response of brain amino acid metabolism to ketosis. Neurochem Int. 2005;47(1-2):119-128.
19. Wong RK, Chuang SC, Bianchi R. Metabotropic Glutamate Receptors and Epileptogenesis. Epilepsy Curr. 2002;2(3):81-85.
20. Skeie B, Petersen AJ, Manner T, Askanazi J, Steen PA. Effects of valine, leucine, isoleucine, and a balanced amino acid solution on the seizure threshold to picrotoxin in rats. Pharmacol Biochem Behav. 1994;48(1):101-103.
21. Aquilani R, Iadarola P, Contardi A, et al. Branched-chain amino acids enhance the cognitive recovery of patients with severe traumatic brain injury. Arch Phys Med Rehabil. 2005;86(9):1729-1735.
22. Scarna A, Mc Tavish SF, Cowen PJ. The effects of a branched chain amino acid mixture supplemented with tryptophan on biochemical indices of neurotransmitter function and decision-making. Psychopharmacology (Berl). 2005;179(4):761-768.
23. Harris RA, Joshi M, Jeoung NH, Obayashi M. Overview of the molecular and biochemical basis of branched-chain amino acid catabolism. J Nutr. 2005;135(6 suppl):1527S-1530S.
24. Dufour F, Nalecz MJ, Nehlig A. Metabolic approach of absence seizures in a genetic model of absence epilepsy, the GAERS: study of the leucine-glutamate cycle. J Neurosci Res. 2001;66(66):923-930.